Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiling Xu

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Journal of Personalized Medicine|February 23, 2024
Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with SarcomaEden C Andrew, Jeremy Lewin, Jayesh Desai, et al.
JCO Precision Oncology|January 7, 2022
Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant PheochromocytomaAngela Mweempwa, Huiling Xu, Joseph H A Vissers, et al.
Pathology|March 28, 2025
The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspectiveChristopher R McEvoy, Catherine Mitchell, Owen W J Prall, et al.
International Journal of Surgical Pathology|January 15, 2020
A Malignant Neoplasm From the Jejunum With a <i>MALAT1-GLI1</i> Fusion and 26-Year Survival HistoryOwen William John Prall, Christopher Robert Edward McEvoy, David John Byrne, et al.
Breast Cancer Research : BCR|January 25, 2011
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersHuiling Xu, Max Yan, Jennifer Patra, et al.
Molecular Diagnosis & Therapy|November 11, 2025
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian LaboratoryAdel Shahnam, Catherine Mitchell, Christopher R McEvoy, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 3, 2020
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumorsChristopher R McEvoy, Holly Holliday, Niko Thio, et al.
JCO Precision Oncology|August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for DeliveryKortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
The Journal of Clinical Investigation|March 6, 2019
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusionChristopher R McEvoy, Huiling Xu, Kortnye Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2020
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast CancerJames R Whittle, François Vaillant, Elliot Surgenor, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Journal of Personalized Medicine|February 23, 2024
Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with SarcomaEden C Andrew, Jeremy Lewin, Jayesh Desai, et al.
JCO Precision Oncology|January 7, 2022
Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant PheochromocytomaAngela Mweempwa, Huiling Xu, Joseph H A Vissers, et al.
Pathology|March 28, 2025
The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspectiveChristopher R McEvoy, Catherine Mitchell, Owen W J Prall, et al.
International Journal of Surgical Pathology|January 15, 2020
A Malignant Neoplasm From the Jejunum With a <i>MALAT1-GLI1</i> Fusion and 26-Year Survival HistoryOwen William John Prall, Christopher Robert Edward McEvoy, David John Byrne, et al.
Breast Cancer Research : BCR|January 25, 2011
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersHuiling Xu, Max Yan, Jennifer Patra, et al.
Molecular Diagnosis & Therapy|November 11, 2025
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian LaboratoryAdel Shahnam, Catherine Mitchell, Christopher R McEvoy, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 3, 2020
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumorsChristopher R McEvoy, Holly Holliday, Niko Thio, et al.
JCO Precision Oncology|August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for DeliveryKortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
The Journal of Clinical Investigation|March 6, 2019
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusionChristopher R McEvoy, Huiling Xu, Kortnye Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2020
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast CancerJames R Whittle, François Vaillant, Elliot Surgenor, et al.
Pageof 13